UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 7,638	$ 6,450
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation	302	325
Amortization	3,257	3,335
Provision for (recovery of) losses on accounts receivable	26	8
Amortization of Right of Use Assets	26	21
Deferred income taxes	(286)	22
Stock-based compensation expense	83	82
Tax benefit attributable to exercise of stock options	0	5
Changes in operating assets and liabilities
Accounts receivable and other receivables	102	(517)
Inventories	(930)	75
Prepaid expenses and other current assets	(47)	(14)
Accounts payable	64	399
Accrued expenses	(357)	34
Total adjustments	2,240	3,775
Net cash provided by operating activities	9,878	10,225
CASH FLOWS FROM INVESTING ACTIVITIES
Property and equipment	(450)	(222)
Intangible assets	(9)	0
Net cash used in investing activities	(459)	(222)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock - options	23	92
Common stock purchased and retired	(2,495)	0
Payment of dividends	(1,060)	(2,077)
Net cash used in financing activities	(3,532)	(1,985)
Effect of exchange rate changes on cash	(637)	(102)
Net increase in cash and cash equivalents	5,250	7,916
Cash at beginning of period	60,974	51,590
Cash at end of period	66,224	59,506
Cash paid during the period for income taxes	2,467	2,279
Cash paid during the period for interest	$ 0	$ 0